|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08307 MEDICSKIN
Nominal 
0.122 -0.046 (-27.381%) Profitability Analysis
| 2026/03 | 2025/03 | 2024/03 | 2023/03 | 2022/03 | |
| ROAA (%) | 1.725% | -6.927% | -7.044% | -6.858% | 6.791% |
| ROAE (%) | 19.871% | -44.596% | -24.519% | -22.570% | 19.190% |
| Return on Capital Employed (%) | 9.219% | -23.900% | -36.635% | -20.572% | 14.631% |
Margin Analysis
| 2026/03 | 2025/03 | 2024/03 | 2023/03 | 2022/03 | |
| Gross Profit Margin (%) | 81.034% | 81.116% | -- | -- | -- |
| EBITDA Margin (%) | 17.192% | 11.710% | 12.451% | 12.964% | 28.694% |
| Pre-tax Profit Margin (%) | 1.926% | -7.677% | -6.358% | -8.131% | 8.995% |
| Net Profit Margin (%) | 1.955% | -7.486% | -6.203% | -7.767% | 7.980% |
Liquidity Analysis
| 2026/03 | 2025/03 | 2024/03 | 2023/03 | 2022/03 | |
| Current Ratio (X) | 0.856 X | 0.858 X | 0.934 X | 0.912 X | 1.008 X |
| Quick Ratio (X) | 0.767 X | 0.774 X | 0.798 X | 0.747 X | 0.918 X |
Leverage Analysis
| 2026/03 | 2025/03 | 2024/03 | 2023/03 | 2022/03 | |
| Total Liabilities / Total Assets(%) | 89.766% | 92.697% | 81.076% | 77.199% | 74.979% |
| Total Debt / Total Assets (%) | 34.414% | 39.681% | 14.371% | 25.658% | 32.939% |
| Net Debt / Total Assets (%) | 11.828% | 9.488% | -2.921% | 14.902% | 7.955% |
| Total Debt / Shareholders' Funds (%) | 336.280% | 543.361% | 52.575% | 85.732% | 107.085% |
| Long Term Debt / Shareholders' Funds (%) | 68.025% | 206.126% | 0% | 37.536% | 68.424% |
| Net Debt / Shareholders' Funds (%) | 115.576% | 129.917% | -10.685% | 49.792% | 25.862% |
| Net Cash / (Debt) ($) | (6.040M) | (5.450M) | 1.170M | (6.927M) | (4.508M) |
| Net Cash / (Debt) per share ($) | (0.015) | (0.014) | 0.003 | (0.017) | (0.011) |
| Total Debt / Capital Employed (%) | 173.092% | 161.316% | 69.195% | 69.371% | 69.634% |
| Interest Coverage Ratio (X) | 2.024 X | N/A | N/A | N/A | 12.164 X |
Efficiency Analysis
| 2026/03 | 2025/03 | 2024/03 | 2023/03 | 2022/03 | |
| Inventory Turnover (Day) | 145.755 Day | 170.266 Day | -- | -- | -- |
| Receivables Turnover (Day) | 4.163 Day | 4.790 Day | 4.323 Day | 3.683 Day | 2.284 Day |
| Payables Turnover (Day) | 5.894 Day | 8.140 Day | 5.564 Day | 2.000 Day | 3.301 Day |
| Remarks: | Real time quote last updated: 24/06/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 936 |
| %Change | -- |
| EPS / (LPS) | HKD 0.002 |
| NBV Per Share ($) | HKD 0.013 |